Bellevue Biotech DT CHF
WKN A1H8PS | ISIN CH0113817123 | Fonds
Fonds
| ISIN | Name | Performance | Volatilität | Sharpe Ratio | ||
|---|---|---|---|---|---|---|
| 1 | CH0113817123 | Bellevue Biotech DT CHF | -1,08 % | +18,46 % | -0,19 |
|
| 2 | LU2026682919 | Candriam Equities L Biotechnology, V2 - Capitalisation | -2,74 % | +18,53 % | -0,27 |
|
| 3 | LU0317020203 | Candriam Equities L Biotechnology, V - Capitalisation | -3,07 % | +18,37 % | -0,29 |
|
| 4 | LU1269736838 | Candriam Equities L Biotechnology, R - Capitalisation | -3,79 % | +18,90 % | -0,32 |
|
| 5 | LU0108459040 | Candriam Equities L Biotechnology C - Thesaurierung | -3,83 % | +18,53 % | -0,33 |
|
| 73 | LU0959058974 | Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse A (acc) CHF-H1 | -14,74 % | +19,63 % | -0,87 |
|
| 74 | DE0009769976 | DWS ESG Biotech LC | -15,57 % | +20,03 % | -0,89 |
|
| 75 | LU1991432631 | UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse (SEK) P-acc, SEK | -17,13 % | +20,73 % | -0,94 |
|
| 76 | DE000A3DCA95 | BIT Biotech Opportunities S | -37,22 % | +29,81 % | -1,33 |
|
| 77 | DE000A3DCBA0 | BIT Biotech Opportunities I-II | -37,30 % | +29,80 % | -1,33 |
|